Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A Brazilian male with IFAP syndrome has a unique genetic variant causing his condition.

Early diagnosis and treatment of biotinidase deficiency are crucial to prevent vision problems.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

IGFBP-5 likely plays a key role in goat hair growth.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Biotin should be added to Japanese amino acid formula to prevent deficiency.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Stopping shaving or removing hair follicles usually resolves Pseudofolliculitis barbae.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Freezia cream helps regrow hair in people with Alopecia Areata.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.